Ch62. Markers of Osteoarthritis: Implications for Early Diagnosis and Monitoring of the Pathological Course and Effects of Therapy

Ch62. Markers of Osteoarthritis: Implications for Early Diagnosis and Monitoring of the Pathological Course and Effects of Therapy

  1. Nelson F, Dahlberg L, Lavery S, et al: Evidence for altered type II collagen in patients with OA, J Clin Invest 102:2115, 1998. PUBMED Abstract
  2. Shinmei M, Ito K, Matasuyama S: Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis, Osteoarthritis Cartilage 1:121, 1993. PUBMED Abstract
  3. Ishiguro N, Ito T, Ito H, et al: Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with OA, Arthritis Rheum 42:129, 1999. PUBMED Abstract
  4. Nelson F, Dahlberg L, Laverty S, et al: Evidence for altered synthesis of type II collagen in patients with OA, J Clin Invest 102:2115, 1998. PUBMED Abstract
  5. Mansson B, Carey D, Alini M, et al: Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism, J Clin Invest 95:1071, 1995. PUBMED Abstract
  6. Lohmander LS, Ionescu M, Jugessur H, et al: Changes in joint cartilage aggrecan after knee injury and in OA, Arthritis Rheum 42:534, 1999. PUBMED Abstract
  7. Poole AR, Dieppe P: Biological markers in rheumatoid arthritis, Semin Arthritis Rheum 23:17, 1994. PUBMED Abstract
  8. Bello AE, Garrett WE Jr, Wang H, et al: Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute knee injury, Osteoarthritis Cartilage 5:419, 1997. PUBMED Abstract
  9. Hazell PK, Dent C, Fairclough JA, et al: Changes in glycosaminoglycan epitope levels in knee joint fluid following injury, Arthritis Rheum 38:953, 1995. PUBMED Abstract
  10. Poole AR: NIH white paper: biomarkers, the OA initiative a basis for discussion, Bethesda, MD, 2000, National Institutes of Health.
  11. Al-Sobayil F, Frisbie DD, Billinghurst RC, et al: Unpublished data, 2000.
  12. Sweet MBE, Coelho A, Schnitzler CM, et al: Serum keratan sulfate levels in OA patients, Arthritis Rheum 31:648, 1988. PUBMED Abstract
  13. Caterson B, Christner JE, Baker JR: Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate, J Biol Chem 258:8848, 1983. PUBMED Abstract
  14. Brandt KD, Thonar EJ-MA: Lack of association between serum keratan sulfate concentrations and cartilage changes of OA after transection of the anterior cruciate ligament in the dog, Arthritis Rheum 32:647, 1989. PUBMED Abstract
  15. Innes JF, Sharif M, Barr AR: Changes in concentrations of biochemical markers of OA following surgical repair of ruptured cranial cruciate ligaments in dogs, Am J Vet Res 60:1164, 1999. PUBMED Abstract
  16. Innes JF, Sharif M, Barr AR: Relations between biochemical markers of OA and other disease parameters in a population of dogs with naturally acquired OA of the genual joint, Am J Vet Res 59:1530, 1998. PUBMED Abstract
  17. Frisbie DD, Ray CS, Ionescu M, et al: Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses, Am J Vet Res 60:306, 1999. PUBMED Abstract
  18. Laverty S, Ionescu M, Marcoux M, et al: Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis, J Orthop Res 18:399, 2000. PUBMED Abstract
  19. Lohmander LS, Saxne T, Heinegard DK: Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in OA, Ann Rheum Dis 53:8, 1994. PUBMED Abstract
  20. Clark AG, Jordan JM, Vilim V, et al: Serum cartilage oligomeric matrix protein reflects OA presence and severity: the Johnston County OA Project, Arthritis Rheum 42:2356, 1999. PUBMED Abstract
  21. Conrozier T, Saxne T, Fan CS, et al: Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip OA: a one year prospective study, Ann Rheum Dis 57:527, 1998. PUBMED Abstract
  22. Sharif M, George E, Dieppe PA: Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in OA of the knee, Arthritis Rheum 38:78, 1995. PUBMED Abstract
  23. Misumi K, Vilim V, Clegg PD, et al: COMP in equine synovial fluids and sera. Havemeyer Symposium Molecular Markers of Cartilage and Bone Metabolism in the Horse, Northampton, UK, 2000.
  24. Arai K, Misumi D, Carter SD, et al: Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease, Equine Vet J 37:31, 2005. PUBMED Abstract
  25. Salisbury C, Sharif M: Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood, Ann Rheum Dis 56:558, 1997. PUBMED Abstract
  26. Lepage OM: Physiological variation in bone markers in horses. Havemeyer Symposium Molecular Markers of Cartilage and Bone Metabolism in the Horse, Northampton, UK, 2000.
  27. Grafenau P, Eicher R, Uebelhart B, et al: General anaesthesia decreases osteocalcin plasma concentrations in horses, Equine Vet J 31:533, 1999. PUBMED Abstract
  28. Fuller CJ, Barr AR, Sharif M, et al: Cross-sectional comparison of synovial fluid biochemical markers in equine OA and the correlation of these markers with articular cartilage damage, Osteoarthritis Cartilage 9:49, 2001. PUBMED Abstract
  29. Bonde M, Garnero P, Fledelius C, et al: Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen, J Bone Miner Res 12:1028, 1997. PUBMED Abstract
  30. Garnero P, Jouvenne P, Buchs N, et al: Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products, Bone 24:381, 1999. PUBMED Abstract
  31. Frisbie D, Billinghurst R: Unpublished data, 2001.
  32. Petersson IF, Boegard T, Dahlstrom J, et al: Bone scan and serum markers of bone and cartilage in patients with knee pain and OA, Osteoarthritis Cartilage 6:33, 1998. PUBMED Abstract
  33. Petersson IF, Boegard T, Svensson B, et al: Changes in cartilage and bone metabolism identified by serum markers in early OA of the knee joint, Br J Rheumatol 37:46, 1998. PUBMED Abstract
  34. Frisbie DD, Al-Sobayil F, Billinghurst RC, et al: Changes in synovial fluid and serum biomarkers with exercise and early OA in horses, Osteoarthritis Cartilage 16:1196, 2008. PUBMED Abstract
  35. Kawcak CE, Frisbie DD, Werpy NM, et al: Effects of exercise vs experimental OA on imaging outcomes, Osteoarthritis Cartilage 16:1519, 2008. PUBMED Abstract
  36. Misumi K, Vilim V, Hatazoe T, et al: Serum level of cartilage oligomeric matrix protein (COMP) in equine OA, Equine Vet J 34:602, 2002. PUBMED Abstract
  37. Taylor SE, Weaver MP, Pitsillides AA, et al: Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with OA of the tarsometatarsal joint compared to a control population, Equine Vet J 38:502, 2006. PUBMED Abstract
  38. Skioldebrand E, Heinegard D, Eloranta ML, et al: Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds, J Orthop Res 23:156, 2005. PUBMED Abstract
  39. Fuller CJ, Barr AR, Sharif M, et al: Cross-sectional comparison of synovial fluid biochemical markers in equine OA and the correlation of these markers with articular cartilage damage, Osteoarthritis Cartilage 9:49, 2001. PUBMED Abstract
  40. Frisbie DD, Duffy E, Arthur R, et al: Prospective clinical study assessing serum biomarkers for musculoskeletal disease in 2- to 3-yr-old racing Thoroughbreds, Proc Am Assoc Equine Pract 51:301, 2005.